Footsie ends the week in profit as US stocks extend rally
Concerns over "the Donald" appear to be easing, and investors took the opportunity to return to equity markets
Company
GSK PLC
LON:GSK
GSK PLC will be a fully focused biopharma company following the demerger of its world-leading consumer healthcare business, Haleon, in July 2022. The company will prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease.
746 stories · page 29 of 38
Hikma Pharmaceuticals hit by downgrade prompted by Advair delay fears
The catalyst for the change is the likely delay to the introduction of a low-cost, copycat version of GlaxoSmithKline’s (LON:GSK) inhaled asthma drug, Advair, being developed by the company.
BP ticks higher as shareholders back CEO's reduced pay at AGM
A look at some of the biggest London-listed risers and fallers today
Neil Woodford returns banks to his portfolio for first time since 2003 with Lloyds investment
Woodford Investment Management said it sees Lloyds as a "well managed bank" with the ability to pay a "very healthy and growing" level of dividend
FTSE 100 closes at record high after third-straight week of gains
At the close, the UK blue chip index was up 0.7%, or 48.8 points at 7,435.4, not far below its all-time record of 7,447.0
Global Invacom shares rocket after it posts a swing to a net profit
A look at some of the biggest London-listed risers and fallers today
Investments and investor services
FTSE 100 finishes little changed after "Super Thursday" underwhelms
The Footsie was back in black - but only just - thanks to precious metals miners
Archive
HSBC may struggle to match rivals
HSBC is the last of the big four banks to report with more uncertainty over the outcome than for its UK-centric rivals.
GlaxoSmithKline shares weak despite being on track to deliver its financial targets for 2017 under new boss Emma Walmsley
The FTSE 100-listed firm said its adjusted earnings per share rose by 31% to 25.0p in the quarter to March 31, beating forecasts for 24.5p
FTSE 100 posts positive finish with all eyes on Trump
The FTSE 100 closed at 7,288 as traders look ahead to Donald Trump's tax plans
Archive
BHP in need of response after activist throws down gauntlet
Day ahead: BHP Billiton, GlaxoSmithKline, Proactis...
FTSE 100 closes over 2% higher as France vote cheers
The FTSE 100 closed 150 points, or 2.11% higher, as investors welcomed Macron's result in the first round of France's presidential election
Archive
BHP Billiton and banks dominate big week for blue chips
Week ahead: Huge for blue chip announcements with four high street banks, the UK’s two pharma giants, mining titans Anglo and BHP and restaurant to coffee chain Whitbread just a few of those updating.
GSK, AT&T and Verizon join advertising boycott on Google over extremist content
Google's promise to crack down on adverts from appearing alongside extremist content has failed to reassure clients
Archive
UK unemployment sees surprise fall, but average earnings growth slowing
The jobless rate fell to 4.7%, down from 4.8% last month, marking its lowest level since the summer of 1975, with economists having expected no change
Barclays Capital analysts "resoundingly positive" on pharma stocks; AstraZeneca top pick
“Our clear preference is for specialty-focus and growth in the context of a strong-catalyst driven thematic or deep value,” Barclays said in a brief note to clients.
Drugs-crazed shoot-out: which investment is best out of Astra, Glaxo and Shire?
We’ve had the final results from Holy Trinity of the UK pharma industry ... which is the one to back?
Investments and investor services
Day Ahead: Shire the big draw with sales of new drug closely monitored
Shire’s results Thursday will update on how 2016 ended as it provides commentary and numbers on the fourth quarter, which will be consolidated to provide full-year numbers too.
GSK announces positive study results for HIV treatment
GSK says the results of its phase three study of its HIV treatment may change our understanding of how the virus can be managed.